Correlation Between Travere Therapeutics and Viking Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Viking Therapeutics, you can compare the effects of market volatilities on Travere Therapeutics and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Viking Therapeutics.

Diversification Opportunities for Travere Therapeutics and Viking Therapeutics

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Travere and Viking is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Viking Therapeutics go up and down completely randomly.

Pair Corralation between Travere Therapeutics and Viking Therapeutics

Given the investment horizon of 90 days Travere Therapeutics is expected to generate 0.76 times more return on investment than Viking Therapeutics. However, Travere Therapeutics is 1.32 times less risky than Viking Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Viking Therapeutics is currently generating about -0.3 per unit of risk. If you would invest  1,757  in Travere Therapeutics on September 2, 2024 and sell it today you would earn a total of  124.00  from holding Travere Therapeutics or generate 7.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Travere Therapeutics  vs.  Viking Therapeutics

 Performance 
       Timeline  
Travere Therapeutics 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Viking Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Travere Therapeutics and Viking Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Travere Therapeutics and Viking Therapeutics

The main advantage of trading using opposite Travere Therapeutics and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.
The idea behind Travere Therapeutics and Viking Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments